Sex Differences in Behavior and Expression of CGRP‐Related Genes in a Rodent Model of Chronic Migraine

Abstract

a. Objective The objectives of this study were to develop a preclinical rodent model that produces migraine-like behaviors based on International Headache Society diagnostic criteria, to determine whether sex differences are present, and to determine whether expression of CGRP and the genes encoding its receptor in trigeminal ganglion or medulla correlates with those behaviors. b. Background Few animal studies of migraine have tested behaviors associated with migraine diagnostic criteria. In this study, changes in activity and in mechanical sensitivity of facial regions following application of inflammatory soup (IS) or vehicle (PBS) to the dura were measured to model changes in routine activity and allodynia. Calcitonin gene related peptide (CGRP), an important mediator of migraine pathogenesis, and the three components of its receptor, calcitonin-like receptor (CLR), receptor activity-modifying protein (RAMP1), and receptor component protein (RCP) mRNAs were quantified in the trigeminal ganglion and medulla to identify baseline sex differences and changes associated with application of IS or PBS to the dura. c. Methods Male and female Sprague-Dawley rats were implanted with a dural cannula. Groups of rats were treated with 10 or 20 microliter volumes of IS or PBS. Baseline behavioral testing was conducted prior to surgery and again at 7 days postsurgery, and dural application of IS or PBS was performed repeatedly for a total of 8 applications. Locomotor activity was assessed using force plate actimetry during and following application to provide information on distance traveled, bouts of low mobility, spatial confinement, and focused energy. Periorbital and perimasseter sensory testing was performed 20 min post-application to measure allodynia. The rats were sacrificed 30 minutes following the final dural treatment, tissue was dissected and total RNAs were isolated from ipsilateral trigeminal ganglia and ipsilateral medulla. Quantitative real-time polymerase chain reactions were used to measure the expression of amplified constructs using gene-specific primers for CGRP, RAMP1, CLR, and RCP. d. Results Both males and females showed behavioral effects of IS application, but there were pronounced sex differences. Females showed effects at the lower dose, and activity changes were present for a longer duration, but males required fewer applications of IS to exhibit behavioral changes. Females showed increased withdrawal responses for periorbital and perimasseter mechanical testing (10 µl IS groups), and males showed increased perimasseter withdrawal responses (20 µl IS group). In the trigeminal ganglion, there were no baseline sex differences in CGRP-encoding mRNA, but females had lower baseline expression of RAMP1, CLR, and RCP-encoding mRNAs. In the medulla, females had higher baseline levels of CGRP-encoding mRNAs and lower baseline levels of RAMP1, CLR, and RCP-encoding mRNAs than males. Both IS and PBS increased expression of mRNAs encoding CGRP, RAMP1, RCP and CLR in the trigeminal ganglion in males, ...

Increased risk of urinary calculi in patients with migraine: A nationwide cohort study

“…Elevated plasma CGRP levels in cranial (26) and systematic circulation were found in patients with migraine, regardless of the presence or aura and outside of attacks (26,27). Of note, CGRP levels were also higher in female than in male patients with migraine (28,29). Moreover, CernudaMorollo´n et al (30) reported higher CGRP levels in patients with chronic migraine (15 headache days per month) than in those with episodic migraine (<15 headache days per month), which might explain our finding that a higher frequency of ambulatory visits for headache within the first year, especially 6 visits, was associated with a greater risk of developing urinary calculi.…”

Behavioral effects and mechanisms of migraine pathogenesis following estradiol exposure in a multibehavioral model of migraine in rat

“…The cannula was implanted through the skull under isoflurane anesthesia as previously described in detail. (Stucky, et al, 2011). Briefly, the cannula was placed on the right side of the skull over the occipital lobe 5 mm lateral to midline and halfway between bregma and lambda.…”

Chronic migraine

“…It is hoped that such models will yield insights into mechanisms of chronic migraine transformation and reversion. [81][82][83][84] A recent study in humans suggests that plasma concentrations of CGRP measured between migraine attacks might serve as a biomarker for chronic migraine. 39 Future studies should evaluate the utility of measuring concentrations of CGRP and other vasoactive neuropeptides to predict transformation, predict treatment responses, and assess early responses to migraine prophylaxis.…”